Benjamin F. Edwards & Company’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$90K Hold
5,830
﹤0.01% 1135
2024
Q1
$96K Buy
5,830
+1,038
+22% +$16.4K ﹤0.01% 1111
2023
Q4
$70K Buy
4,792
+930
+24% +$13K ﹤0.01% 1176
2023
Q3
$56K Sell
3,862
-105
-3% -$1.64K ﹤0.01% 1045
2023
Q2
$65K Hold
3,967
﹤0.01% 1019
2023
Q1
$66K Buy
3,967
+3,457
+678% +$55.7K ﹤0.01% 1028
2022
Q4
$8K Buy
+510
New +$7.9K ﹤0.01% 1465
2020
Q4
Sell
-215
Closed -$5K 1604
2020
Q3
$5K Buy
+215
New +$4.96K ﹤0.01% 1408

Other funds holding BMEZ

Benjamin F. Edwards & Company's BMEZ Position: Q2 2024 in Review

Benjamin F. Edwards & Company held its BlackRock Health Sciences Trust II (BMEZ) position steady in Q2 2024 at 5,830 shares worth $90K. The position accounts for ﹤0.01% of the portfolio, ranked #1135.

Benjamin F. Edwards & Company first reported a position in BMEZ in Q3 2020 and has held it in 8 quarters since. The position peaked at $96K in Q1 2024. 92 funds tracked by Wall St. Rank hold BMEZ as of Q2 2024.

  • Benjamin F. Edwards & Company held 5,830 shares of BlackRock Health Sciences Trust II worth $90K as of Q2 2024.
  • Benjamin F. Edwards & Company left its BlackRock Health Sciences Trust II share count unchanged in Q2 2024.
  • BlackRock Health Sciences Trust II made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1135 holding.
  • Benjamin F. Edwards & Company first reported a position in BlackRock Health Sciences Trust II in Q3 2020 and has held it in 8 quarters since.
  • Benjamin F. Edwards & Company's BlackRock Health Sciences Trust II position peaked at $96K in Q1 2024.
  • 92 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.